DeutschNewstral
Article
Haaretz on 2015-04-20 00:09
Mylan chief: Acquisition by Teva not feasible
Related news
Mylan rejects Teva Pharmaceutical's takeover bidpost-gazette.com
The Teva vs. Mylan drug warThe Jerusalem Post (JPost.com)
Teva brings in new advisor for proposed Mylan dealbizjournals.com
Teva offers to buy Mylan in $40 billion dealtimesofisrael.com- FTeva set to lift Mylan bid to up to $43bnft.com
Teva CEO: Company’s proposal to Mylan is ‘strong and serious’observer-reporter.com- Report: Teva getting ready to up its offer for Mylanbizjournals.com
- Teva ends hostile bid for Mylanbizjournals.com
- Teva still targets Mylan despite rejectionThe Jerusalem Post (JPost.com)
- Teva fires back at Mylan, defending bid, attacking Mylan bossHaaretz
Teva makes $40.1B unsolicited bid for MylanThe Salt Lake Tribune- Teva offers to buy Mylan for $40.1Bobserver-reporter.com
Teva makes $40B offer for MylanArkansas Online- Teva buying up shares of Mylanbizjournals.com
- HTeva Shares Up on Mylan-Pfizer Mergerhamodia.com
- Mylan shareholders approve Perrigo acquisitionbizjournals.com
- HMylan Overtakes Teva in Market Caphamodia.com
Teva pursuit of drugmaker Mylan shares affords chance to sway shareholderstriblive.com- Teva Pharmaceutical says its offer to buy Mylan is 'strong and serious'post-gazette.com